Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 101 views

    Untitled

    Uploaded by

    api-271638639
    Hematology and Medical Oncology Board Review: Contemporary Practice from MSK. Four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease. Lecture topics will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Untitled

    Uploaded by

    api-271638639
    101 views8 pages
    Hematology and Medical Oncology Board Review: Contemporary Practice from MSK. Four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease. Lecture topics will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin.

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Hematology and Medical Oncology Board Review: Contemporary Practice from MSK. Four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease. Lecture topics will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    101 views8 pages

    Untitled

    Uploaded by

    api-271638639
    Hematology and Medical Oncology Board Review: Contemporary Practice from MSK. Four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease. Lecture topics will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 8

    JOIN US FOR OUR THIRD ANNUAL

    Hematology and Medical


    Oncology Board Review:

    Contemporary Practice from


    Memorial Sloan Kettering

    March 6-9, 2015


    C O U R S E LO C AT I O N

    Memorial Sloan Kettering Cancer Center


    ZUCKERMAN RESEARCH CENTER
    417 East 68th Street between First and York Avenues

    NEW YORK

    www.mskcc.org/
    hemoncreviewcourse
    To register and for more information, go to:

    SCIENTIFIC AGENDA:

    Hematology and Medical


    Oncology Board Review:
    Contemporary Practice from MSK
    COURSE OVERVIEW
    This four day course will provide an up-to-date and
    comprehensive review of the diagnosis, staging, and
    management of neoplastic disease, including solid tumor
    and hematologic oncology. Lectures will focus on disease
    specific topics in gastrointestinal, gynecologic, thoracic,
    head and neck, genitourinary, soft tissue and skin, and
    central nervous system oncology, as well as hematologic
    oncology.

    TARGET AUDIENCE
    The target audience is physicians who are either
    oncology fellows in training, or practicing oncologists in
    both academic and private practice.

    EDUCATIONAL OBJECTIVES
    After this activity, participants will return to practice with
    an understanding of the:
    1. State-of-the-science in diagnosis, staging, and therapeutic
    management of solid tumor cancers;
    2. State-of-the-science in diagnosis, staging, and therapeutic
    management of hematologic cancers;
    3. Recent treatment advances in solid tumor and hematologic
    oncology and their impact on modern clinical practice.

    FOUR DAYS FEATURING:


    State-of-the-science in diagnosis, staging, and


    therapeutic management of solid tumor cancers;
    State-of-the-science in diagnosis, staging, and
    therapeutic management of hematologic cancers;
    Recent treatment advances in solid tumor and
    hematologic

    www.mskcc.org/hemoncreviewcourse

    SCIENTIFIC AGENDA:

    Hematology and Medical


    Oncology Board Review:
    Contemporary Practice from MSK

    COURSE DIRECTORS

    David Ilson MD PhD


    Attending Physician
    Gastrointestinal Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Craig Moskowitz MD
    Steven A. Greenberg Chair in Lymphoma Research
    Clinical Director, Division of Hematologic Oncology
    Attending Physician, Lymphoma and
    Adult BMT Services
    Member, Memorial Sloan Kettering Cancer Center
    Professor of Medicine, Weill Medical
    College of Cornell University

    MSK PHYSICIAN IN CHIEF

    Jos Baselga MD PhD


    Physician in Chief
    Department of Medicine
    Breast Medicine Service

    www.mskcc.org/hemoncreviewcourse

    SCIENTIFIC AGENDA:

    Hematology and Medical


    Oncology Board Review:
    Contemporary Practice from MSK
    COURSE FACULTY
    Ghassan Abou-Alfa MD

    Steven Horwitz MD

    Carol Aghajanian MD

    Clifford Hudis MD

    Dean Bajorin MD

    David Hyman MD

    Associate Attending Physician


    Gastrointestinal Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Attending Physician, Chief


    Gynecologic Medical Oncology Svc, Department of
    Medicine
    Division of Solid Tumor Oncology

    Attending Physician
    Genitourinary Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    George Bosl MD

    Attending Physician
    Genitourinary Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology
    Attending Physician, Chair
    Department of Medicine

    Paul Chapman MD
    Attending Physician
    Melanoma and Sarcoma Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Chau Dang MD

    Associate Attending Physician


    Breast Medicine Service
    Division of Solid Tumor Oncology

    Mark Dickson MD

    Assistant Attending Physician


    Sarcoma Medical Oncology Service
    Division of Solid Tumor Oncology
    Department of Mediciney

    Sergio Andres Giralt MD

    Attending Physician, Chief, Bone Marrow Transplant Service


    Attending Physician, Lymphoma Service
    Attending Physician, Acting Chief, Myeloma Service
    Department of Medicine - Division of Hematologic
    Oncology

    Paul Hamlin MD

    Assistant Attending Physician


    Lymphoma Service
    Department of Medicine
    Division of Hematologic Oncology

    Associate Attending Physician


    Lymphoma Service
    Department of Medicine
    Division of Hematologic Oncology

    Attending Physician, Chief


    Breast Cancer Medicine Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Assistant Attending Physician


    Gynecologic Medical Oncology Service, Division of
    Solid Tumor Oncology, Department of Medicine

    Lee M Krug MD

    Associate Attending Physician


    Thoracic Oncology Service
    Division of Solid Tumor Oncolog
    Department of Medicine

    Simon Mantha MD
    Associate Attending Physician
    Hematology Service
    Department of Medicine
    Division of Hematologic Oncology

    Michael Mauro MD
    Attending Physician
    Leukemia Service
    Department of Medicine
    Division of Hematologic Oncology

    Robert Motzer MD
    Attending Physician
    Genitourinary Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Kenneth Offit MD
    Attending Physician, Chief
    Vice Chair for Academic Affairs
    Clinical Genetics Service
    Department of Medicine

    Eileen OReilly MBBCh BAO


    Associate Attending Physician
    Gastrointestinal Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Antonio Omuro MD
    Assistant Attending Neurologist
    Neurology Service
    Department of Neurology

    www.mskcc.org/hemoncreviewcourse

    SCIENTIFIC AGENDA:

    Hematology and Medical


    Oncology Board Review:
    Contemporary Practice from MSK
    COURSE FACULTY
    Rekha Parameswaran MBBS
    Associate Attending Physician
    Hematology Service
    Department of Medicine
    Division of Hematologic Oncology
    Associate Attending Physician
    Blood Bank, Cytotherapy Lab Svc
    Department of Laboratory Medicine

    Jae Park MD

    Assistant Attending Physician


    Leukemia Service
    Department of Medicine
    Division of Hematologic Oncology

    Miguel Perales MD
    Associate Attending Physician
    Bone Marrow Transplant Service
    Department of Medicine
    Division of Hematologic Oncology

    David Pfister MD

    Attending Physician, Chief


    Head and Neck Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Maria Pietanza MD
    Assistant Attending Physician
    Thoracic Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Charles Rudin MD PhD


    Attending Physician, Chief
    Thoracic Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Leonard Saltz MD

    Attending Physician, Chief


    Gastrointestinal Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Paul Sabbatini MD

    Attending Physician
    Vice Chairman, Clinical Trials Office, Gynecologic
    Medical Oncology Svc, Department of Medicine

    Craig Sauter MD

    Assistant Attending Physician


    Bone Marrow Transplant Service
    Department of Medicine
    Division of Hematologic Oncology

    Howard Scher MD
    Attending Physician, Chief
    Genitourinary Oncology Service
    Department of Medicine

    Andrew Seidman MD
    Attending Physician
    Breast Cancer Medicine Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Susan Seo MD

    Associate Attending Physician


    Infectious Disease Service
    Department of Medicine
    Division of General Medicine

    Larry Smith MD
    Assistant Attending,
    Laboratory Medicine

    Gerald Soff MD

    Attending Physician, Chief


    Hematology Service
    Department of Medicine
    Division of Hematologic Oncology
    Attending Physician
    Hematology Laboratory Service

    Martin Tallman MD
    Attending Physician, Chief
    Leukemia Service
    Department of Medicine
    Division of Hematologic Oncology

    Anas Younes MD

    Attending Physician, Chief


    Lymphoma Service
    Department of Medicine
    Division of Hematologic Oncology

    Marjorie Zauderer MD
    Assistant Attending Physician
    Thoracic Oncology Service
    Department of Medicine
    Division of Solid Tumor Oncology

    Andrew Zelenetz MD PhD


    Attending Physician
    Lymphoma Service
    Department of Medicine
    Division of Hematologic Oncology

    www.mskcc.org/hemoncreviewcourse

    SCIENTIFIC AGENDA:

    Hematology and Medical


    Oncology Board Review:
    Contemporary Practice from MSK

    Friday, March 6

    Saturday, March 7

    7:00-8:00am

    REGISTRATION & BREAKFAST

    7:00-8:00am

    Medicine Grand Rounds

    7:45-8:00am Mesothelioma

    Colorectal Cancer:
    Advanced Disease /
    Adjuvant Therapy

    8:00-8:45am

    Ovarian Cancer

    8:45-9:30am

    Cervix / Uterine /
    Other GYN Cancers

    8:00-9:00am

    Jos Baselga MD PhD

    9:00-10:00am

    Leonard Saltz MD
    10:00-10:45am
    10:45-11:30am
    11:30am-12:15pm

    12:15p-1:00pm
    1:00-1:45pm
    1:45-2:45pm

    Prostate Cancer
    Howard Scher MD

    Marjorie Zauderer MD

    Paul Sabbatini MD

    Carol Aghajanian MD

    9:30-10:15am

    Breast Cancer
    Adjuvant Therapy

    Testis Cancer

    George Bosl MD

    Kidney Cancer

    Robert Motzer MD
    LUNCH

    Urothelial Cancers

    Chau Dang MD
    10:15-10:30am

    COFFEE BREAK

    10:30-11:15am

    Hepatobiliary Cancer

    11:15am-12:00pm

    Pancreatic Cancer /
    Neuroendocrine
    Cancer

    Dean Bajorin MD

    Non Small Cell Lung


    Cancer: Advanced
    Disease and Adjuvant
    Therapy

    Small Cell Lung Cancer

    Lee M Krug MD

    3:15-3:30pm

    COFFEE BREAK

    3:30-4:15pm

    Cancer Genetics

    4:15-5:00pm

    Breast Cancer:
    Advanced Disease

    Kenneth Offit MD

    Andrew Seidman MD
    5:00-6:00pm Melanoma

    Paul Chapman MD

    Ghassan Abou-Alfa MD

    Eileen OReilly MBBCh BAO

    12:00-1:00pm

    LUNCH

    1:00-1:45pm

    Gastric and
    Esophageal Cancer

    Charles Rudin MD PhD


    2:45-3:15pm

    BREAKFAST

    David Ilson MD PhD


    1:45-2:30pm

    Head and Neck /


    Thyroid Cancer
    David Pfister MD

    2:30-3:15pm

    Pharmacology I

    3:15-3:30pm

    COFFEE BREAK

    3:30-4:00pm
    4:00-4:30pm

    David Hyman MD

    Pharmacology II

    David Hyman MD

    Central Nervous
    System Cancers

    Antonio Omuro MD

    4:30-5:00pm Sarcoma

    Mark Andrew Dickson MD

    5:00-6:00pm

    Infectious Disease

    Susan Seo MD

    www.mskcc.org/hemoncreviewcourse

    SCIENTIFIC AGENDA:

    Hematology and Medical


    Oncology Board Review:
    Contemporary Practice from MSK

    Sunday, March 8

    7:00-8:00am

    BREAKFAST

    8:00-8:30am

    Chronic Lymphocytic
    Leukemia / Small
    Lymphocytic
    Lymphoma and Hairy
    Cell Leukemia
    Jae Park MD

    3:15-3:45pm

    Hematopoietic Stem
    Cell Transplantation
    (Autologous /
    Allogeneic)
    Sergio Giralt MD

    3:45-4:15pm

    Complications of
    Hematopoietic Stem
    Cell Transplantation

    8:30-9:00am Myelodysplastic

    Syndromes and
    Myeloproliferative
    Disorders

    Michael Mauro MD
    9:00-9:45am

    Acute Myelogenous
    Leukemia and Acute
    Lymphoblastic
    Leukemia
    Martin Tallman MD

    9:45-10.00am

    COFFEE BREAK

    10:00-11:00am

    Multiple Myeloma

    11:00-11:45am

    C. Ola Landrgren MD PhD

    T-Cell / Cutaneous
    Lymphoma
    Steven Horwitz MD

    1:30-2:00pm
    2:00-2:30pm

    Monday, March 9

    7:00-8:00am

    BREAKFAST

    8:00-8:45am

    Interpretation of
    Coagulation Testing
    Larry Smith MD

    8:45-9:30am

    Approach to the
    Bleeding Patient

    Rekha Parameswaran MD

    9:30-10:15am Thrombosis:

    Pathophysiology and
    Management

    Indolent Lymphomas

    Andrew Zelenetz MD PhD

    11:45am-1:00pm LUNCH
    1:00-1:30pm

    Miguel Perales MD

    Gerald Soff MD
    10:15-10:30am

    COFFEE BREAK

    10:30-11:15am Thrombocytopenia

    Gerald Soff MD

    11:15-11:30am

    Update on Use of
    The New Oral
    Anticoagulants

    Hodgkin Lymphoma

    Craig Moskowitz MD

    Aggressive Lymphomas
    (Diffuse Large B- Cell
    Lymphoma and Mantle
    Cell Lymphoma)

    Simon Mantha MD

    11:30am-12:00pm CLOSING REMARKS

    Paul Hamlin MD

    2:30-3:00pm

    Mantle Cell Lymphoma


    and Waldenstrms
    Macroglobulinemia
    Anas Younes MD

    3:00-3:15pm

    COFFEE BREAK

    www.mskcc.org/hemoncreviewcourse

    REGISTRATION

    $1,400.00 MDs, PhDs and DOs


    $ 875.00 Fellows, Residents and RNs
    Registration fee includes an electronic syllabus and other related hand-out materials,
    continental breakfast, lunch, and refreshment breaks. Special meals are available
    upon request, including vegetarian, kosher, or gluten-free. Please let us know if
    we can assist you with special dietary needs. The course will be held on the campus of
    Memorial Sloan Kettering on the Upper East Side of Manhattan. Breakfast and lunch
    will be provided daily.
    To register to attend please go to:

    www.mskcc.org/hemoncreviewcourse
    Or contact:

    OFFICE OF CONTINUING MEDICAL EDUCATION

    Memorial Sloan Kettering Cancer Center


    633 Third Avenue, 12th floor, New York, New York 10017

    (646) 227-2025 | brodheap@mskcc.org

    TARGET AUDIENCE

    Radiologist and Nuclear Medicine Physicians


    who interpret oncologic FDG PET/CT.
    COURSE DESIGN

    This course is comprised of lectures


    and interactive audience participation
    encouraging the intellectual exchange of
    ideas between faculty and participants.
    EVALUATION

    A course evaluation survey sent out


    electronically will provide attendees with
    the opportunity to review the sessions
    and the speakers and to identify future
    educational needs.
    AMA CREDIT DESIGNATION STATEMENT

    MSK designates this live activity for a


    maximum of 26.25 AMA PRA Category
    1 Credits. Physicians should only claim
    credit commensurate with the extent of their
    participation in the activity. The AMA has
    determined that physicians not licensed in
    the United States but who participate in this
    CME activity are eligible for 26.25 AMA
    PRA Category 1 Credits.
    ACCREDITATION STATEMENT

    MSK is accredited by the Accreditation


    Council for Continuing Medical Education
    (ACCME) to provide continuing medical
    education for physicians.

    FACULTY DISCLOSURE

    It is the policy of MSK to make every


    effort to insure balance, independence,
    objectivity, and scientific rigor in all
    continuing medical education activities
    which it sponsors as an ACCME accredited
    provider. In accordance with ACCME
    guidelines and standards, all faculty
    participating in an activity sponsored
    by MSK are expected to disclose any
    significant financial interest or other
    relationship with the manufacturer(s)
    of any commercial product(s) and/or
    provider(s) of commercial services which
    are discussed by the faculty members in
    an educational presentation. As required
    by the ACCME, when an unlabeled use of
    a commercial product or an investigational
    use not yet approved for any purpose is
    discussed during an educational activity,
    MSK requires the speaker to disclose that
    the product is not labeled for the use
    under discussion or that the product is still
    investigational.
    OUTCOMES MEASUREMENT SURVEY

    Six months after the end of the course


    an Outcomes Measurement Survey will
    be sent to all participants to help us
    determine what positive impacts have
    been made on participant practice as a
    result of the course.

    You might also like